As Vioxx Deadline Looms, Merck Faces More Suits

Pharmaceutical giant Merck & Co. may be plunged into even deeper hot water in the next few days over its painkiller Vioxx, as plaintiffs attorneys rush to file additional lawsuits ahead...

Already a subscriber? Click here to view full article